Summary of opinion: Rezolsta, 25/06/2026 Positive
Summary of opinion: Rezolsta, 25/06/2026 Positive
Summary of opinion: Rezolsta, 25/06/2026 Positive
Summary of opinion: Jaypirca, 25/06/2026 Positive
Summary of opinion: Ixchiq, 25/06/2026 Positive
Summary of opinion: Rinvoq, 25/06/2026 Positive
Summary of opinion: Imvanex, 25/06/2026 Positive
European Medicines Agency’s data protection notice for sharing contact details of network representatives in Agile teams via the restricted Network Portfolio website
Human medicines European public assessment report (EPAR): Feraccru, ferric maltol, Date of authorisation: 18/02/2016, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Date of authorisation: 31/07/2013, Revision: 21, Status: Authorised
Summary of opinion: Stelara, 25/06/2026 Positive
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 24, Status: Authorised